🔍 RecallPedia

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Class I - Dangerous
💊 Drugs Recalled: August 24, 2024 Rubicon Research Private Limited Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Rubicon Research Private Limited
Reason for Recall:
Discoloration
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
ongoing

Product Information

Full Description:

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Product Codes/Lot Numbers:

Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0659-2024

Related Recalls